Laurus Labs Ltd. Financials

15:59 Oct 29

Laurus Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
961.70
+2.05 (+0.21%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Laurus Labs Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
961.70
+2.05 (+0.21%)
15:59 Oct 29
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

70/100
Technically Bullish

Strength

13

Weakness

4

Opportunity

1

Threats

0

8.01 %

ROE %

3.83 %

ROA %

12.67

EPS

82.99

BVPS

6.45 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
4935.57 6040.55 5040.83 5553.96 5928.62
Operating Expenses +
3513.14 4448.36 4263.33 4498.68 4662.41
Raw Material
2414.94 2752.28 2533.3 2533.91 2577.1
Increase Decrease in Cost
-221.17 22.04 -100.88 -55.93 1.38
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
501.53 580.64 639.93 719.52 760.34
Miscellaneous Expenses
1109.46 1404.82 1412.82 1511.9 1323.59
Operating Profit
1422.43 1592.19 777.5 1055.28 1266.21
Other Income
13.58 6 26.34 59.93 83.02
Depreciation
251.49 324.08 384.58 430.09 440.87
Interest
100.67 165.17 182.9 200.83 218.31
Profit before tax and exceptio..
1083.85 1108.94 236.36 484.29 690.05
Exceptional Items
0 0 0 0 0
PBT
1083.85 1108.94 236.36 484.29 690.05
Provision for Taxation
251.42 312.3 68.15 129.88 186.77
Net Profit
832.43 796.64 168.21 354.41 503.28
NET Profit after MI
827.52 790.11 160.55 358.32 508.83
EPS
15.42 14.64 2.97 6.64 9.44
Operating Profit Margin (%)
28.82 26.36 15.42 19 21.36
Net Profit Margin (%)
16.77 13.08 3.19 6.45 8.58

Laurus Labs Ltd. Shareholding

All Data in Percentage (%)

Sep 25 Jun 25 Mar 25 Dec 24 Sep 24
Promoter 27.60 27.60 27.60 27.60 27.20
FII 26.20 25.70 25.50 25.60 26.10
MF 8.50 7.80 6.90 7.60 8.20
Others 3.20 4.10 4.90 5.10 4.80
Shareholder Shares Holding %
Download Our App On: